</ iframe></noscript> <!-- End Google Tag Manager (noscript) --> <div id="page" class="site"><a aria-label="skip to content" class="skip-link" href="#content">Skip to Content</a> <header class="site-header header-layout-three header-layout-seven header-layout-eight" itemscope itemtype="http://schema.org/WPHeader"> <div class="header-holder"> <div class="header-m" style="background-image:url(https://blog.covance.com/wp-content/uploads/2020/04/cropped-dna-blog-header-4.jpg)"> <div class="container"> <div class="site-branding" itemscope itemtype="http://schema.org/Organization"> <h1 class="site-title" itemprop="name"><a href="https://blog.covance.com/" rel="home" itemprop="url">Insights From Our Labs to Yours</a></h1> <p class="site-description" itemprop="description">Covance by LabCorp Blog</p> </div> </div> </div> </div> <div class="sticky-holder"></div> <div class="header-b"> <div class="container"> <button aria-label="primary menu toggle" id="primary-toggle-button"><i class="fa fa-bars"></i>Navigation</button> <nav id="site-navigation" class="main-navigation" itemscope itemtype="http://schema.org/SiteNavigationElement"> <div class="menu-main-container"><ul id="primary-menu" class="menu"><li id="menu-item-6077" class="menu-item menu-item-type-custom menu-item-object-custom current-menu-item current_page_item menu-item-home menu-item-6077"><a href="https://blog.covance.com" aria-current="page">Home</a></li> <li id="menu-item-5821" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5821"><a href="https://blog.covance.com/industry/">Industry</a> <ul class="sub-menu"> <li id="menu-item-5824" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5824"><a href="https://blog.covance.com/industry/device/">Device</a></li> <li id="menu-item-5825" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5825"><a href="https://blog.covance.com/industry/drug-development/">Drug</a></li> <li id="menu-item-5822" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5822"><a href="https://blog.covance.com/industry/chemical/">Chemical</a></li> <li id="menu-item-5823" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5823"><a href="https://blog.covance.com/industry/crop/">Crop</a></li> </ul> </li> <li id="menu-item-5828" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5828"><a href="https://blog.covance.com/phase/">Phase</a> <ul class="sub-menu"> <li id="menu-item-5829" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5829"><a href="https://blog.covance.com/phase/discovery/">Discovery</a></li> <li id="menu-item-5835" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5835"><a href="https://blog.covance.com/phase/preclinical-nonclinical/">Preclinical/Nonclinical</a></li> <li id="menu-item-5831" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5831"><a href="https://blog.covance.com/phase/phase-i-iia/">Phase I-IIa</a></li> <li id="menu-item-5832" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5832"><a href="https://blog.covance.com/phase/phase-iib-iii/">Phase IIb-III</a></li> <li id="menu-item-5833" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5833"><a href="https://blog.covance.com/phase/pilot/">Pilot</a></li> <li id="menu-item-5834" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5834"><a href="https://blog.covance.com/phase/pivotal/">Pivotal</a></li> <li id="menu-item-5830" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5830"><a href="https://blog.covance.com/phase/formulation-packaging/">Formulation, Packaging, etc.</a></li> </ul> </li> <li id="menu-item-5836" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5836"><a href="https://blog.covance.com/molecule-type/">Molecule Type</a> <ul class="sub-menu"> <li id="menu-item-5837" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5837"><a href="https://blog.covance.com/molecule-type/biologics/">Biologics</a></li> <li id="menu-item-5841" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5841"><a href="https://blog.covance.com/molecule-type/small-molecules/">Small Molecules</a></li> <li id="menu-item-5839" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5839"><a href="https://blog.covance.com/molecule-type/biosimilars/">Biosimilars</a></li> <li id="menu-item-5838" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5838"><a href="https://blog.covance.com/molecule-type/biomarkers/">Biomarkers</a></li> <li id="menu-item-5840" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5840"><a href="https://blog.covance.com/molecule-type/cell-gene-therapies/">Cell/Gene Therapies</a></li> </ul> </li> <li id="menu-item-5844" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5844"><a href="https://blog.covance.com/data-informatics/">Data/Informatics</a> <ul class="sub-menu"> <li id="menu-item-5842" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5842"><a href="https://blog.covance.com/data-informatics/send/">SEND</a></li> <li id="menu-item-5845" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5845"><a href="https://blog.covance.com/data-informatics/modeling/">Modeling</a></li> <li id="menu-item-5846" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5846"><a href="https://blog.covance.com/data-informatics/patient-recruitment/">Patient Recruitment</a></li> <li id="menu-item-5843" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5843"><a href="https://blog.covance.com/data-informatics/xcellerate/">Xcellerate</a></li> </ul> </li> <li id="menu-item-5827" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5827"><a href="https://blog.covance.com/about-covance/">About Us</a> <ul class="sub-menu"> <li id="menu-item-5704" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5704"><a href="https://blog.covance.com/about-covance/careers-and-culture/">Careers and Culture</a></li> <li id="menu-item-5792" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5792"><a href="http://response.covance.com/contact-us?elqCampaignId=399&cid=Web_Clk_CVD_blog_megamenunav_0615_399">Contact Us</a></li> <li id="menu-item-5791" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5791"><a href="https://www.covance.com">Covance.com</a></li> </ul> </li> </ul></div> </nav><!-- #site-navigation --> <div class="right"> <div class="tools"> <div class="form-section"> <button aria-label="search form toggle" id="btn-search"><i class="fa fa-search"></i></button> <div class="form-holder"> <form role="search" method="get" class="search-form" action="https://blog.covance.com/"> <label> <span class="screen-reader-text">Search for:</span> <input type="search" class="search-field" placeholder="Search …" value="" name="s" /> </label> <input type="submit" class="search-submit" value="Search" /> </form> </div> </div> </div> <ul class="social-networks"> <li><a href="https://www.linkedin.com/company/covancebylabcorp" target="_blank" rel="nofollow"><i class="fab fa-linkedin"></i></a></li> <li><a href="https://twitter.com/covance" target="_blank" rel="nofollow"><i class="fab fa-twitter-square"></i></a></li> <li><a href="https://www.facebook.com/CovanceByLabcorp" target="_blank" rel="nofollow"><i class="fab fa-facebook"></i></a></li> <li><a href="http://www.youtube.com/user/CovanceMedia" target="_blank" rel="nofollow"><i class="fab fa-youtube"></i></a></li> </ul> </div> </div> </div> </header> <div class="banner banner-layout-two"> <div class="container"> <div class="owl-carousel slider-layout-two"> <div class="item"><div class="grid-holder"> <div class="grid-item image-size"> <img width="817" height="649" src="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg" class="attachment-blossom-feminine-slider-two-big size-blossom-feminine-slider-two-big wp-post-image" alt="Diabetic Kidney Disease" srcset="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg 817w, https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-300x238.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-768x610.jpg 768w, https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-76x60.jpg 76w" sizes="(max-width: 817px) 100vw, 817px" data-attachment-id="7842" data-permalink="https://blog.covance.com/2021/04/recognizing-national-kidney-month-by-breaking-down-barriers-to-improve-clinical-trials-for-glomerular-diseases/biomarkers-for-diabetic-kidney-disease-3/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg" data-orig-size="817,649" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease-300x238.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/04/Biomarkers-for-Diabetic-Kidney-Disease.jpg" /> <div class="text-holder"> <h2 class="title"><a href="https://blog.covance.com/2021/04/recognizing-national-kidney-month-by-breaking-down-barriers-to-improve-clinical-trials-for-glomerular-diseases/">Recognizing National Kidney Month by Breaking Down Barriers to Improve Clinical Trials for Glomerular Diseases</a></h2> </div> </div> <div class="grid-item"> <img width="460" height="310" src="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-460x310.jpg" class="attachment-blossom-feminine-slider-two size-blossom-feminine-slider-two wp-post-image" alt="DCTBlog" srcset="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-460x310.jpg 460w, https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-91x60.jpg 91w" sizes="(max-width: 460px) 100vw, 460px" data-attachment-id="7836" data-permalink="https://blog.covance.com/2021/03/decentralized-clinical-trials/dctblog/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog.jpg" data-orig-size="618,407" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog-300x198.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/04/DCTBlog.jpg" /> <div class="text-holder"> <h2 class="title"><a href="https://blog.covance.com/2021/03/decentralized-clinical-trials/">Decentralized Clinical Trials (DCT) Monthly Blog – March 2021</a></h2> </div> </div> <div class="grid-item"> <img width="454" height="310" src="https://blog.covance.com/wp-content/uploads/2021/03/KP2-454x310.jpg" class="attachment-blossom-feminine-slider-two size-blossom-feminine-slider-two wp-post-image" alt="KP2" data-attachment-id="7804" data-permalink="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/kp2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2.jpg" data-orig-size="454,606" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2-225x300.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/KP2.jpg" /> <div class="text-holder"> <h2 class="title"><a href="https://blog.covance.com/2021/03/expanding-clinical-trial-support-in-europe-the-middle-east-and-africa-with-a-new-automated-kit-production-line/">Expanding clinical trial support in Europe, the Middle East and Africa with a new automated kit production line</a></h2> </div> </div> </div></div> </div> </div> </div> <div class="container main-content"> <div id="content" class="site-content"> <div class="row"> <div id="primary" class="content-area"> <main id="main" class="site-main"> <article id="post-7799" class="post-7799 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-phase-i-iia tag-clinical-pharmacology tag-clinical-trials wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-450x300.png" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Leeds-Image" data-attachment-id="7800" data-permalink="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/leeds-image-updated-03-15-21-1/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1.png" data-orig-size="1287,601" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-300x140.png" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/Leeds-Image-Updated-03.15.21-1-1024x478.png" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/&title=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Covance%20by%20Labcorp%20Announces%20Plans%20for%20New%20Clinical%20Pharmacology%20Site%20in%20Leeds,%20UK&Body=https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="bookmark">Covance by Labcorp Announces Plans for New Clinical Pharmacology Site in Leeds, UK</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/covance-by-labcorp-announces-plans-for-new-clinical-pharmacology-site-in-leeds-uk/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-23T09:25:20-04:00" itemprop="dateModified">Tuesday, March 23, 2021</time><time class="updated" datetime="2021-03-23T09:25:16-04:00" itemprop="datePublished">Tuesday, March 23, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Work is underway to transform an existing building in the heart of Leeds’s Temple district into a fit-for-purpose facility that will raise the bar for clinical conduct and volunteer engagement. The new site will consolidate our two existing central Leeds locations into one facility just minutes away from hospitals and … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7799 --> <article id="post-7756" class="post-7756 post type-post status-publish format-standard has-post-thumbnail hentry category-discovery category-drug-development category-oncology category-phase-i-iia tag-flow-cytometry wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Greenfield3801" srcset="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-300x200.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-1024x683.jpg 1024w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-768x512.jpg 768w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801.jpg 1500w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7760" data-permalink="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/greenfield3801/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801.jpg" data-orig-size="1500,1000" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-300x200.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/Greenfield3801-1024x683.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/&title=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Minimal%20Residual%20Disease%20by%20Flow%20Cytometry:%20Latest%20Insights%20on%20Validation&Body=https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="bookmark">Minimal Residual Disease by Flow Cytometry: Latest Insights on Validation</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/minimal-residual-disease-by-flow-cytometry-latest-insights-on-validation/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-22T16:43:59-04:00" itemprop="dateModified">Monday, March 22, 2021</time><time class="updated" datetime="2021-03-22T16:43:56-04:00" itemprop="datePublished">Monday, March 22, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Despite the development of cellular and antibody-based therapeutics that eliminate malignant cells, patients who have achieved complete remission or response may experience relapse. Increasing evidence suggests that the presence of measurable/minimal residual disease (MRD) in bone marrow (BM) tissue is one, if not the strongest, prognostic factor for disease outcome … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7756 --> <article id="post-7811" class="post-7811 post type-post status-publish format-standard has-post-thumbnail hentry category-discovery category-drug-development category-phase-i-iia wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="3-22-2021 1-19-21 PM" data-attachment-id="7812" data-permalink="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/3-22-2021-1-19-21-pm/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM.jpg" data-orig-size="828,408" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM-300x148.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/3-22-2021-1-19-21-PM.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/&title=5%20Reasons%20Not%20to%20Miss%20Our%20Neurology%20Biomarker%20Virtual%20Workshop%20on%20April%2015" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=5%20Reasons%20Not%20to%20Miss%20Our%20Neurology%20Biomarker%20Virtual%20Workshop%20on%20April%2015 https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=5%20Reasons%20Not%20to%20Miss%20Our%20Neurology%20Biomarker%20Virtual%20Workshop%20on%20April%2015&Body=https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="bookmark">5 Reasons Not to Miss Our Neurology Biomarker Virtual Workshop on April 15</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/5-reasons-not-to-miss-our-neurology-biomarker-virtual-workshop-on-april-15/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-23T16:30:09-04:00" itemprop="dateModified">Tuesday, March 23, 2021</time><time class="updated" datetime="2021-03-22T16:35:21-04:00" itemprop="datePublished">Monday, March 22, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>On April 15, 2021, we’ll be hosting our virtual workshop, “Advancing Your Neurodegenerative Biomarker Strategy Beyond Discovery.” Read on to learn more about our reasons for organizing the event, and insights that will be on offer. Then be sure to sign up to reserve your spot.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7811 --> <article id="post-7806" class="post-7806 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-metabolic-endocrine category-preclinical-nonclinical tag-qwba wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/lab1-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Lab1" srcset="https://blog.covance.com/wp-content/uploads/2021/03/lab1-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/lab1-300x199.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/lab1-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/lab1.jpg 906w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7810" data-permalink="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/lab1/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/lab1.jpg" data-orig-size="906,601" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/lab1-300x199.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/lab1.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/&title=Quantitative%20Whole%20Body%20Autoradiography%20(QWBA):%20Your%20Questions%20Answered" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Quantitative%20Whole%20Body%20Autoradiography%20(QWBA):%20Your%20Questions%20Answered https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Quantitative%20Whole%20Body%20Autoradiography%20(QWBA):%20Your%20Questions%20Answered&Body=https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="bookmark">Quantitative Whole Body Autoradiography (QWBA): Your Questions Answered</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/quantitative-whole-body-autoradiography-qwba-your-questions-answered/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-22T14:27:30-04:00" itemprop="dateModified">Monday, March 22, 2021</time><time class="updated" datetime="2021-03-22T14:27:26-04:00" itemprop="datePublished">Monday, March 22, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>QWBA helps characterize the distribution of a drug within the body and provides vital metabolic information to inform your preclinical drug development program. Here we gain advice from two experienced study leaders on common QWBA questions and challenges.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7806 --> <article id="post-7783" class="post-7783 post type-post status-publish format-standard has-post-thumbnail hentry category-device category-phase-i-iia tag-eu-mdr tag-med-device wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/EU-450x300.png" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="EU" srcset="https://blog.covance.com/wp-content/uploads/2021/03/EU-450x300.png 450w, https://blog.covance.com/wp-content/uploads/2021/03/EU-300x200.png 300w, https://blog.covance.com/wp-content/uploads/2021/03/EU-1024x682.png 1024w, https://blog.covance.com/wp-content/uploads/2021/03/EU-768x512.png 768w, https://blog.covance.com/wp-content/uploads/2021/03/EU-90x60.png 90w, https://blog.covance.com/wp-content/uploads/2021/03/EU.png 1280w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7784" data-permalink="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/eu/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/EU.png" data-orig-size="1280,853" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/EU-300x200.png" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/EU-1024x682.png" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/&title=EU%20MDR%20and%20IVDR%20Implementation%20and%20Deadlines" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=EU%20MDR%20and%20IVDR%20Implementation%20and%20Deadlines https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=EU%20MDR%20and%20IVDR%20Implementation%20and%20Deadlines&Body=https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="bookmark">EU MDR and IVDR Implementation and Deadlines</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/lilianaomar/">Liliana Omar, Regulatory and Quality Project Director</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/eu-mdr-and-ivdr-implementation-and-deadlines/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-15T15:46:19-04:00" itemprop="dateModified">Monday, March 15, 2021</time><time class="updated" datetime="2021-03-15T15:46:16-04:00" itemprop="datePublished">Monday, March 15, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Proposal for EU MDR Application Delay The European Medical Device Regulation (MDR) and In-Vitro Diagnostics Regulation (IVDR) entered into force on 25 May 2017 replacing the Medical Device Directive (MDD), the Active Implantable Medical Device Directive (AIMD) and the In-Vitro Diagnostics Directive (IVDD).</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7783 --> <article id="post-7765" class="post-7765 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-phase-i-iia category-phase-iib-iii category-xcellerate tag-big-data tag-internet-of-things tag-patient-care-technology tag-xcellerate wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="3-15-2021" srcset="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-300x200.jpg 300w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-90x60.jpg 90w, https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg 542w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7792" data-permalink="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/3-15-2021-1-04-34-pm/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg" data-orig-size="542,361" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM-300x200.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/3-15-2021-1-04-34-PM.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/&title=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Six%20Automated%20Clinical%20Alerts%20You%20Need%20to%20Increase%20Efficiency%20in%20your%20Clinical%20Trials&Body=https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="bookmark">Six Automated Clinical Alerts You Need to Increase Efficiency in your Clinical Trials</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/gaylekeenan/">Gayle Keenan, Associate Director, Xcellerate CS</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-18T15:46:50-04:00" itemprop="dateModified">Thursday, March 18, 2021</time><time class="updated" datetime="2021-03-15T14:08:15-04:00" itemprop="datePublished">Monday, March 15, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>What is an automated clinical alert? Automated clinical alerts continuously monitor study data and send alerts and notifications to clinical trial project team members based on specific study, country, site or subject performance criteria to help boost clinical study monitoring and improve quality management.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7765 --> <article id="post-7772" class="post-7772 post type-post status-publish format-standard has-post-thumbnail hentry category-chemical category-preclinical-nonclinical tag-chemical-testing tag-reach tag-regulatory wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="ncblog1" data-attachment-id="7775" data-permalink="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/ncblog1/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1.jpg" data-orig-size="823,621" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1-300x226.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/ncblog1.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/&title=Overcoming%20challenges%20in%20the%20processes%20of%20characterization,%20assessment,%20and%20registration%20of%20your%20UVCB%20in%20Europe " rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Overcoming%20challenges%20in%20the%20processes%20of%20characterization,%20assessment,%20and%20registration%20of%20your%20UVCB%20in%20Europe https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Overcoming%20challenges%20in%20the%20processes%20of%20characterization,%20assessment,%20and%20registration%20of%20your%20UVCB%20in%20Europe &Body=https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="bookmark">Overcoming challenges in the processes of characterization, assessment, and registration of your UVCB in Europe </a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/03/overcoming-challenges-in-the-processes-of-characterization-assessment-and-registration-of-your-uvcb-in-europe%e2%80%83/" rel="bookmark"><time class="entry-date published updated" datetime="2021-04-05T15:19:47-04:00" itemprop="dateModified">Monday, April 5, 2021</time><time class="updated" datetime="2021-03-08T17:51:41-05:00" itemprop="datePublished">Monday, March 8, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>The demand under European regulations for detailed environmental risk assessment of UCVBs is challenging both the industry and regulators alike. Read on to explore the challenges and possible ways of overcoming them.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7772 --> <article id="post-7752" class="post-7752 post type-post status-publish format-standard has-post-thumbnail hentry category-commercialization category-decentralized-clinical-trials category-drug-development category-phase-i-iia category-phase-iib-iii category-pivotal tag-decentralized-clinical-trials-dct wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="DCT2" srcset="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-450x300.jpg 450w, https://blog.covance.com/wp-content/uploads/2021/03/DCT2-89x60.jpg 89w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="7753" data-permalink="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/dct2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2.jpg" data-orig-size="537,361" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2-300x202.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/03/DCT2.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/&title=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021 https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Decentralized%20Clinical%20Trials%20(DCT)%20Monthly%20Blog%20–%20February%202021&Body=https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="bookmark">Decentralized Clinical Trials (DCT) Monthly Blog – February 2021</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/janemyles/">Jane Myles, Director, Covance by Labcorp Decentralized Clinical Trials Implementation</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/02/decentralized-clinical-trials-dct-monthly-blog-february-2021/" rel="bookmark"><time class="entry-date published updated" datetime="2021-03-09T17:22:23-05:00" itemprop="dateModified">Tuesday, March 9, 2021</time><time class="updated" datetime="2021-02-25T17:19:00-05:00" itemprop="datePublished">Thursday, February 25, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Welcome to the February 2021 edition of the Covance by Labcorp Decentralized Clinical Trials Blog. Most of our blogs focus on interesting things we hear from sponsors, new developments at Covance by Labcorp, or interesting challenges we encounter as we partner with sponsors. This month, however, we want to take … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7752 --> <article id="post-7733" class="post-7733 post type-post status-publish format-standard has-post-thumbnail hentry category-crop category-preclinical-nonclinical category-vaccine-molecule-type tag-endocrine-disruptor wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/02/Tractor-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Tractor" data-attachment-id="7736" data-permalink="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/tractor/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/02/Tractor.jpg" data-orig-size="642,411" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/02/Tractor-300x192.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/02/Tractor.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/&title=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements&Body=https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="bookmark">Pesticide active ingredient renewal: how to negotiate the EU endocrine disruptor requirements</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/hyacinth-chin-sue/">Hyacinth Chin Sue, Expert Consultant, CPC Crop Protection</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="bookmark"><time class="entry-date published updated" datetime="2021-02-16T14:35:03-05:00" itemprop="dateModified">Tuesday, February 16, 2021</time><time class="updated" datetime="2021-02-15T14:46:30-05:00" itemprop="datePublished">Monday, February 15, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>ED assessment of active substances in PPPs came into effect in November 2018 in the EU. Insights from EFSA’s assessment of the first 65 actives shows how guidance is applied and how waivers are being used. Read on to find out how to negotiate the ED assessment process and when … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7733 --> <article id="post-7713" class="post-7713 post type-post status-publish format-standard has-post-thumbnail hentry category-drug-development category-oncology category-phase-i-iia category-phase-iib-iii wow fadeIn latest_post" data-wow-delay="0.1s" itemscope itemtype="https://schema.org/Blog"> <div class="img-holder"><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" class="post-thumbnail"><img width="450" height="300" src="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="MMM" data-attachment-id="7719" data-permalink="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/1-29-2021-2-36-58-pm-2/" data-orig-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1.jpg" data-orig-size="803,598" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1-300x223.jpg" data-large-file="https://blog.covance.com/wp-content/uploads/2021/01/1-29-2021-2-36-58-PM-1.jpg" /></a></div> <div class="text-holder"> <header class="entry-header"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/&title=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="mailto:?Subject=Innovation%20in%20Plasma%20Cell%20Enrichment%20for%20Multiple%20Myeloma%20Studies&Body=https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> <h2 class="entry-title" itemprop="headline"><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="bookmark">Innovation in Plasma Cell Enrichment for Multiple Myeloma Studies</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://blog.covance.com/author/covance/">Covance by Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://blog.covance.com/2021/02/innovation-in-plasma-cell-enrichment-for-multiple-myeloma-studies/" rel="bookmark"><time class="entry-date published updated" datetime="2021-01-29T16:48:29-05:00" itemprop="dateModified">Friday, January 29, 2021</time><time class="updated" datetime="2021-02-08T07:00:00-05:00" itemprop="datePublished">Monday, February 8, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Syndecan-1 (SDC1), also known as CD138, is a well-known and specific plasma cell marker that is highly expressed on the surface of multiple myeloma plasma cells. As it can be a challenge detecting the small number of malignant plasma cells within the large proportion of cells obtained from a bone … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7713 --><div class="pagination"></div> </main><!-- #main --> </div><!-- #primary --> <aside id="secondary" class="widget-area" itemscope itemtype="http://schema.org/WPSideBar"> <section id="nav_menu-7" class="widget widget_nav_menu"><h2 class="widget-title" itemprop="name">Languages:</h2><div class="menu-languages-container"><ul id="menu-languages" class="menu"><li id="menu-item-2536" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2536"><a href="https://zh.covance.com/sdblog/">简体中文</a></li> <li id="menu-item-2537" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2537"><a href="https://fr.covance.com/sdblog/">Français</a></li> <li id="menu-item-2538" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2538"><a href="https://de.covance.com/sdblog/">Deutsch</a></li> <li id="menu-item-2539" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2539"><a href="https://ja.covance.com/sdblog/">日本語</a></li> <li id="menu-item-2540" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2540"><a href="https://es.covance.com/sdblog/">Español</a></li> <li id="menu-item-2543" class="menu-item menu-item-type-custom menu-item-object-custom current-menu-item current_page_item menu-item-home menu-item-2543"><a href="https://blog.covance.com/" aria-current="page">English</a></li> </ul></div></section><section id="categories-2" class="widget widget_categories"><h2 class="widget-title" itemprop="name">Category</h2> <ul> <li class="cat-item cat-item-477"><a href="https://blog.covance.com/about-covance/">About Covance by LabCorp</a> (1) </li> <li class="cat-item cat-item-94"><a href="https://blog.covance.com/industry/drug-development/analytical-services/">Analytical Services</a> (3) </li> <li class="cat-item cat-item-586"><a href="https://blog.covance.com/industry/drug-development/antibodies/">Antibodies</a> (1) </li> <li class="cat-item cat-item-491"><a href="https://blog.covance.com/therapeutic-area/autoimmune-inflammatory/">Autoimmune/Inflammatory</a> (11) </li> <li class="cat-item cat-item-512"><a href="https://blog.covance.com/molecule-type/biologics/">Biologics</a> (13) </li> <li class="cat-item cat-item-515"><a href="https://blog.covance.com/molecule-type/biomarkers/">Biomarkers</a> (11) </li> <li class="cat-item cat-item-514"><a href="https://blog.covance.com/molecule-type/biosimilars/">Biosimilars</a> (4) </li> <li class="cat-item cat-item-492"><a href="https://blog.covance.com/therapeutic-area/cardiology/">Cardiology</a> (3) </li> <li class="cat-item cat-item-286"><a href="https://blog.covance.com/about-covance/careers-and-culture/">Careers and Culture</a> (58) </li> <li class="cat-item cat-item-516"><a href="https://blog.covance.com/molecule-type/cell-gene-therapies/">Cell/Gene Therapies</a> (5) </li> <li class="cat-item cat-item-458"><a href="https://blog.covance.com/industry/chemical/">Chemical</a> (15) </li> <li class="cat-item cat-item-11"><a href="https://blog.covance.com/industry/drug-development/clinical-development/">Clinical Development</a> (45) </li> <li class="cat-item cat-item-10"><a href="https://blog.covance.com/industry/drug-development/central-laboratory-services/">Clinical Testing</a> (12) </li> <li class="cat-item cat-item-585"><a href="https://blog.covance.com/phase/commercialization/">Commercialization</a> (7) </li> <li class="cat-item cat-item-180"><a href="https://blog.covance.com/industry/drug-development/consulting/">Consulting</a> (3) </li> <li class="cat-item cat-item-479"><a href="https://blog.covance.com/industry/crop/">Crop</a> (13) </li> <li class="cat-item cat-item-517"><a href="https://blog.covance.com/data-informatics/">Data/Informatics</a> (15) </li> <li class="cat-item cat-item-632"><a href="https://blog.covance.com/decentralized-clinical-trials/">Decentralized Clinical Trials</a> (9) </li> <li class="cat-item cat-item-478"><a href="https://blog.covance.com/industry/device/">Device</a> (15) </li> <li class="cat-item cat-item-481"><a href="https://blog.covance.com/phase/discovery/">Discovery</a> (6) </li> <li class="cat-item cat-item-64"><a href="https://blog.covance.com/industry/drug-development/">Drug</a> (177) </li> <li class="cat-item cat-item-486"><a href="https://blog.covance.com/phase/formulation-packaging/">Formulation, Packaging, etc.</a> (1) </li> <li class="cat-item cat-item-495"><a href="https://blog.covance.com/therapeutic-area/general-medicine/">General Medicine</a> (2) </li> <li class="cat-item cat-item-181"><a href="https://blog.covance.com/industry/drug-development/health-economics-market-access/">Health Economics & Market Access</a> (5) </li> <li class="cat-item cat-item-19"><a href="https://blog.covance.com/healthcare/">Healthcare</a> (1) </li> <li class="cat-item cat-item-571"><a href="https://blog.covance.com/industry/drug-development/immunology/">Immunology</a> (2) </li> <li class="cat-item cat-item-487"><a href="https://blog.covance.com/industry/">Industry</a> (1) </li> <li class="cat-item cat-item-497"><a href="https://blog.covance.com/therapeutic-area/infectious-disease/">Infectious Disease</a> (3) </li> <li class="cat-item cat-item-603"><a href="https://blog.covance.com/routes/inhalation/">Inhalation</a> (1) </li> <li class="cat-item cat-item-99"><a href="https://blog.covance.com/industry/drug-development/lead-optimization-drug-development/">Lead Optimization</a> (7) </li> <li class="cat-item cat-item-61"><a href="https://blog.covance.com/industry/drug-development/manufacturing-support/">Manufacturing Support</a> (1) </li> <li class="cat-item cat-item-432"><a href="https://blog.covance.com/therapeutic-area/metabolic-endocrine/">Metabolic/Endocrine</a> (11) </li> <li class="cat-item cat-item-569"><a href="https://blog.covance.com/industry/drug-development/metabolism-pk/">Metabolism & PK</a> (3) </li> <li class="cat-item cat-item-499"><a href="https://blog.covance.com/therapeutic-area/nash/">NASH</a> (6) </li> <li class="cat-item cat-item-500"><a href="https://blog.covance.com/therapeutic-area/nephrology/">Nephrology</a> (1) </li> <li class="cat-item cat-item-501"><a href="https://blog.covance.com/therapeutic-area/oncology/">Oncology</a> (37) </li> <li class="cat-item cat-item-614"><a href="https://blog.covance.com/industry/drug-development/safety-assessment/pathology/">Pathology</a> (1) </li> <li class="cat-item cat-item-520"><a href="https://blog.covance.com/data-informatics/patient-recruitment/">Patient Recruitment</a> (9) </li> <li class="cat-item cat-item-503"><a href="https://blog.covance.com/therapeutic-area/pediatrics/">Pediatrics</a> (2) </li> <li class="cat-item cat-item-482"><a href="https://blog.covance.com/phase/phase-i-iia/">Phase I-IIa</a> (20) </li> <li class="cat-item cat-item-483"><a href="https://blog.covance.com/phase/phase-iib-iii/">Phase IIb-III</a> (74) </li> <li class="cat-item cat-item-484"><a href="https://blog.covance.com/phase/pilot/">Pilot</a> (2) </li> <li class="cat-item cat-item-485"><a href="https://blog.covance.com/phase/pivotal/">Pivotal</a> (7) </li> <li class="cat-item cat-item-460"><a href="https://blog.covance.com/phase/preclinical-nonclinical/">Preclinical/Nonclinical</a> (99) </li> <li class="cat-item cat-item-504"><a href="https://blog.covance.com/therapeutic-area/pulmonary-respiratory/">Pulmonary/Respiratory</a> (5) </li> <li class="cat-item cat-item-505"><a href="https://blog.covance.com/therapeutic-area/rare-disease/">Rare Disease</a> (8) </li> <li class="cat-item cat-item-565"><a href="https://blog.covance.com/regulatory/regulatory-agencies/">Regulatory Agencies</a> (2) </li> <li class="cat-item cat-item-566"><a href="https://blog.covance.com/regulatory/regulatory-milestones/">Regulatory Milestones</a> (1) </li> <li class="cat-item cat-item-506"><a href="https://blog.covance.com/therapeutic-area/renal-hepatic/">Renal/Hepatic</a> (2) </li> <li class="cat-item cat-item-507"><a href="https://blog.covance.com/therapeutic-area/reproductive-health/">Reproductive Health</a> (1) </li> <li class="cat-item cat-item-431"><a href="https://blog.covance.com/safety/risk-management/">Risk Management</a> (4) </li> <li class="cat-item cat-item-602"><a href="https://blog.covance.com/routes/">Routes</a> (1) </li> <li class="cat-item cat-item-238"><a href="https://blog.covance.com/safety/">Safety</a> (3) </li> <li class="cat-item cat-item-179"><a href="https://blog.covance.com/industry/drug-development/safety-assessment/">Safety Assessment</a> (9) </li> <li class="cat-item cat-item-518"><a href="https://blog.covance.com/data-informatics/send/">SEND</a> (7) </li> <li class="cat-item cat-item-513"><a href="https://blog.covance.com/molecule-type/small-molecules/">Small Molecules</a> (7) </li> <li class="cat-item cat-item-430"><a href="https://blog.covance.com/technology-services/">Technology Services</a> (2) </li> <li class="cat-item cat-item-1"><a href="https://blog.covance.com/uncategorized/">Uncategorized</a> (2) </li> <li class="cat-item cat-item-510"><a href="https://blog.covance.com/therapeutic-area/vaccine/">Vaccine</a> (4) </li> <li class="cat-item cat-item-570"><a href="https://blog.covance.com/molecule-type/vaccine-molecule-type/">Vaccine</a> (2) </li> <li class="cat-item cat-item-521"><a href="https://blog.covance.com/data-informatics/xcellerate/">Xcellerate</a> (6) </li> </ul> </section><section id="archives-2" class="widget widget_archive"><h2 class="widget-title" itemprop="name">Archives</h2> <label class="screen-reader-text" for="archives-dropdown-2">Archives</label> <select id="archives-dropdown-2" name="archive-dropdown"> <option value="">Select Month</option> <option value='https://blog.covance.com/2021/04/'> April 2021 </option> <option value='https://blog.covance.com/2021/03/'> March 2021 </option> <option value='https://blog.covance.com/2021/02/'> February 2021 </option> <option value='https://blog.covance.com/2021/01/'> January 2021 </option> <option value='https://blog.covance.com/2020/12/'> December 2020 </option> <option value='https://blog.covance.com/2020/11/'> November 2020 </option> <option value='https://blog.covance.com/2020/10/'> October 2020 </option> <option value='https://blog.covance.com/2020/09/'> September 2020 </option> <option value='https://blog.covance.com/2020/08/'> August 2020 </option> <option value='https://blog.covance.com/2020/07/'> July 2020 </option> <option value='https://blog.covance.com/2020/06/'> June 2020 </option> <option value='https://blog.covance.com/2020/05/'> May 2020 </option> <option value='https://blog.covance.com/2020/04/'> April 2020 </option> <option value='https://blog.covance.com/2020/03/'> March 2020 </option> <option value='https://blog.covance.com/2020/02/'> February 2020 </option> <option value='https://blog.covance.com/2020/01/'> January 2020 </option> <option value='https://blog.covance.com/2019/12/'> December 2019 </option> <option value='https://blog.covance.com/2019/10/'> October 2019 </option> <option value='https://blog.covance.com/2019/09/'> September 2019 </option> <option value='https://blog.covance.com/2019/08/'> August 2019 </option> <option value='https://blog.covance.com/2019/05/'> May 2019 </option> <option value='https://blog.covance.com/2019/04/'> April 2019 </option> <option value='https://blog.covance.com/2019/03/'> March 2019 </option> <option value='https://blog.covance.com/2019/02/'> February 2019 </option> <option value='https://blog.covance.com/2019/01/'> January 2019 </option> <option value='https://blog.covance.com/2018/12/'> December 2018 </option> <option value='https://blog.covance.com/2018/11/'> November 2018 </option> <option value='https://blog.covance.com/2018/10/'> October 2018 </option> <option value='https://blog.covance.com/2018/09/'> September 2018 </option> <option value='https://blog.covance.com/2018/08/'> August 2018 </option> <option value='https://blog.covance.com/2018/07/'> July 2018 </option> <option value='https://blog.covance.com/2018/06/'> June 2018 </option> <option value='https://blog.covance.com/2018/05/'> May 2018 </option> <option value='https://blog.covance.com/2018/03/'> March 2018 </option> <option value='https://blog.covance.com/2018/02/'> February 2018 </option> <option value='https://blog.covance.com/2018/01/'> January 2018 </option> <option value='https://blog.covance.com/2017/12/'> December 2017 </option> <option value='https://blog.covance.com/2017/11/'> November 2017 </option> <option value='https://blog.covance.com/2017/10/'> October 2017 </option> <option value='https://blog.covance.com/2017/09/'> September 2017 </option> <option value='https://blog.covance.com/2017/08/'> August 2017 </option> <option value='https://blog.covance.com/2017/07/'> July 2017 </option> <option value='https://blog.covance.com/2017/06/'> June 2017 </option> <option value='https://blog.covance.com/2017/05/'> May 2017 </option> <option value='https://blog.covance.com/2017/04/'> April 2017 </option> <option value='https://blog.covance.com/2017/03/'> March 2017 </option> <option value='https://blog.covance.com/2017/02/'> February 2017 </option> <option value='https://blog.covance.com/2017/01/'> January 2017 </option> <option value='https://blog.covance.com/2016/12/'> December 2016 </option> <option value='https://blog.covance.com/2016/11/'> November 2016 </option> <option value='https://blog.covance.com/2016/09/'> September 2016 </option> <option value='https://blog.covance.com/2016/08/'> August 2016 </option> <option value='https://blog.covance.com/2016/07/'> July 2016 </option> <option value='https://blog.covance.com/2016/06/'> June 2016 </option> <option value='https://blog.covance.com/2016/05/'> May 2016 </option> <option value='https://blog.covance.com/2016/04/'> April 2016 </option> <option value='https://blog.covance.com/2016/03/'> March 2016 </option> <option value='https://blog.covance.com/2016/02/'> February 2016 </option> <option value='https://blog.covance.com/2016/01/'> January 2016 </option> <option value='https://blog.covance.com/2015/11/'> November 2015 </option> <option value='https://blog.covance.com/2015/08/'> August 2015 </option> <option value='https://blog.covance.com/2015/06/'> June 2015 </option> <option value='https://blog.covance.com/2015/03/'> March 2015 </option> </select> <script type="text/javascript"> /* <![CDATA[ */ (function() { var dropdown = document.getElementById( "archives-dropdown-2" ); function onSelectChange() { if ( dropdown.options[ dropdown.selectedIndex ].value !== '' ) { document.location.href = this.options[ this.selectedIndex ].value; } } dropdown.onchange = onSelectChange; })(); /* ]]> */ </script> </section><section id="tag_cloud-2" class="widget widget_tag_cloud"><h2 class="widget-title" itemprop="name">Tags</h2><div class="tagcloud"><a href="https://blog.covance.com/tag/biologics/" class="tag-cloud-link tag-link-88 tag-link-position-1" style="font-size: 9.4736842105263pt;" aria-label="biologics (5 items)">biologics</a> <a href="https://blog.covance.com/tag/biomarkers/" class="tag-cloud-link tag-link-20 tag-link-position-2" style="font-size: 16.842105263158pt;" aria-label="Biomarkers (14 items)">Biomarkers</a> <a href="https://blog.covance.com/tag/biosimilars/" class="tag-cloud-link tag-link-62 tag-link-position-3" style="font-size: 11.684210526316pt;" aria-label="biosimilars (7 items)">biosimilars</a> <a href="https://blog.covance.com/tag/cancer/" class="tag-cloud-link tag-link-44 tag-link-position-4" style="font-size: 8pt;" aria-label="cancer (4 items)">cancer</a> <a href="https://blog.covance.com/tag/careers/" class="tag-cloud-link tag-link-282 tag-link-position-5" style="font-size: 19.052631578947pt;" aria-label="Careers (19 items)">Careers</a> <a href="https://blog.covance.com/tag/cdx/" class="tag-cloud-link tag-link-79 tag-link-position-6" style="font-size: 8pt;" aria-label="CDx (4 items)">CDx</a> <a href="https://blog.covance.com/tag/central-laboratory-services-2/" class="tag-cloud-link tag-link-76 tag-link-position-7" style="font-size: 10.763157894737pt;" aria-label="central laboratory services (6 items)">central laboratory services</a> <a href="https://blog.covance.com/tag/china/" class="tag-cloud-link tag-link-266 tag-link-position-8" style="font-size: 11.684210526316pt;" aria-label="China (7 items)">China</a> <a href="https://blog.covance.com/tag/clinical-development/" class="tag-cloud-link tag-link-267 tag-link-position-9" style="font-size: 10.763157894737pt;" aria-label="Clinical Development (6 items)">Clinical Development</a> <a href="https://blog.covance.com/tag/clinical-trials/" class="tag-cloud-link tag-link-152 tag-link-position-10" style="font-size: 16.289473684211pt;" aria-label="clinical trials (13 items)">clinical trials</a> <a href="https://blog.covance.com/tag/cmc/" class="tag-cloud-link tag-link-605 tag-link-position-11" style="font-size: 9.4736842105263pt;" aria-label="CMC (5 items)">CMC</a> <a href="https://blog.covance.com/tag/commercialization/" class="tag-cloud-link tag-link-189 tag-link-position-12" style="font-size: 13.526315789474pt;" aria-label="commercialization (9 items)">commercialization</a> <a href="https://blog.covance.com/tag/companion-diagnostics/" class="tag-cloud-link tag-link-39 tag-link-position-13" style="font-size: 10.763157894737pt;" aria-label="Companion Diagnostics (6 items)">Companion Diagnostics</a> <a href="https://blog.covance.com/tag/covance/" class="tag-cloud-link tag-link-14 tag-link-position-14" style="font-size: 18.315789473684pt;" aria-label="Covance (17 items)">Covance</a> <a href="https://blog.covance.com/tag/covid-19/" class="tag-cloud-link tag-link-550 tag-link-position-15" style="font-size: 17.763157894737pt;" aria-label="COVID-19 (16 items)">COVID-19</a> <a href="https://blog.covance.com/tag/cra/" class="tag-cloud-link tag-link-274 tag-link-position-16" style="font-size: 9.4736842105263pt;" aria-label="CRA (5 items)">CRA</a> <a href="https://blog.covance.com/tag/cro/" class="tag-cloud-link tag-link-156 tag-link-position-17" style="font-size: 10.763157894737pt;" aria-label="CRO (6 items)">CRO</a> <a href="https://blog.covance.com/tag/crop-protection/" class="tag-cloud-link tag-link-453 tag-link-position-18" style="font-size: 11.684210526316pt;" aria-label="Crop Protection (7 items)">Crop Protection</a> <a href="https://blog.covance.com/tag/dart/" class="tag-cloud-link tag-link-82 tag-link-position-19" style="font-size: 8pt;" aria-label="dart (4 items)">dart</a> <a href="https://blog.covance.com/tag/data-management/" class="tag-cloud-link tag-link-271 tag-link-position-20" style="font-size: 8pt;" aria-label="data management (4 items)">data management</a> <a href="https://blog.covance.com/tag/decentralized-clinical-trials-dct/" class="tag-cloud-link tag-link-591 tag-link-position-21" style="font-size: 13.526315789474pt;" aria-label="Decentralized Clinical Trials (DCT) (9 items)">Decentralized Clinical Trials (DCT)</a> <a href="https://blog.covance.com/tag/decentralized-trials/" class="tag-cloud-link tag-link-588 tag-link-position-22" style="font-size: 9.4736842105263pt;" aria-label="Decentralized Trials (5 items)">Decentralized Trials</a> <a href="https://blog.covance.com/tag/diabetes/" class="tag-cloud-link tag-link-335 tag-link-position-23" style="font-size: 11.684210526316pt;" aria-label="Diabetes (7 items)">Diabetes</a> <a href="https://blog.covance.com/tag/diabetic-kidney-disease/" class="tag-cloud-link tag-link-369 tag-link-position-24" style="font-size: 10.763157894737pt;" aria-label="Diabetic Kidney Disease (6 items)">Diabetic Kidney Disease</a> <a href="https://blog.covance.com/tag/drug-development/" class="tag-cloud-link tag-link-268 tag-link-position-25" style="font-size: 22pt;" aria-label="Drug Development (28 items)">Drug Development</a> <a href="https://blog.covance.com/tag/drug-safety/" class="tag-cloud-link tag-link-291 tag-link-position-26" style="font-size: 11.684210526316pt;" aria-label="Drug Safety (7 items)">Drug Safety</a> <a href="https://blog.covance.com/tag/fda/" class="tag-cloud-link tag-link-97 tag-link-position-27" style="font-size: 16.842105263158pt;" aria-label="FDA (14 items)">FDA</a> <a href="https://blog.covance.com/tag/informatics/" class="tag-cloud-link tag-link-270 tag-link-position-28" style="font-size: 9.4736842105263pt;" aria-label="informatics (5 items)">informatics</a> <a href="https://blog.covance.com/tag/market-access/" class="tag-cloud-link tag-link-203 tag-link-position-29" style="font-size: 12.605263157895pt;" aria-label="Market Access (8 items)">Market Access</a> <a href="https://blog.covance.com/tag/med-device/" class="tag-cloud-link tag-link-555 tag-link-position-30" style="font-size: 9.4736842105263pt;" aria-label="Med Device (5 items)">Med Device</a> <a href="https://blog.covance.com/tag/medical-device/" class="tag-cloud-link tag-link-445 tag-link-position-31" style="font-size: 9.4736842105263pt;" aria-label="medical device (5 items)">medical device</a> <a href="https://blog.covance.com/tag/nafld/" class="tag-cloud-link tag-link-269 tag-link-position-32" style="font-size: 8pt;" aria-label="NAFLD (4 items)">NAFLD</a> <a href="https://blog.covance.com/tag/nash/" class="tag-cloud-link tag-link-251 tag-link-position-33" style="font-size: 10.763157894737pt;" aria-label="NASH (6 items)">NASH</a> <a href="https://blog.covance.com/tag/patient-centricity/" class="tag-cloud-link tag-link-353 tag-link-position-34" style="font-size: 14.263157894737pt;" aria-label="Patient Centricity (10 items)">Patient Centricity</a> <a href="https://blog.covance.com/tag/patient-recruitment/" class="tag-cloud-link tag-link-355 tag-link-position-35" style="font-size: 13.526315789474pt;" aria-label="Patient Recruitment (9 items)">Patient Recruitment</a> <a href="https://blog.covance.com/tag/pharmacovigilance/" class="tag-cloud-link tag-link-438 tag-link-position-36" style="font-size: 11.684210526316pt;" aria-label="Pharmacovigilance (7 items)">Pharmacovigilance</a> <a href="https://blog.covance.com/tag/precision-medicine/" class="tag-cloud-link tag-link-328 tag-link-position-37" style="font-size: 10.763157894737pt;" aria-label="precision medicine (6 items)">precision medicine</a> <a href="https://blog.covance.com/tag/rare-diseases/" class="tag-cloud-link tag-link-264 tag-link-position-38" style="font-size: 10.763157894737pt;" aria-label="Rare Diseases (6 items)">Rare Diseases</a> <a href="https://blog.covance.com/tag/reach/" class="tag-cloud-link tag-link-301 tag-link-position-39" style="font-size: 11.684210526316pt;" aria-label="REACH (7 items)">REACH</a> <a href="https://blog.covance.com/tag/real-world-evidence/" class="tag-cloud-link tag-link-449 tag-link-position-40" style="font-size: 10.763157894737pt;" aria-label="Real-World Evidence (6 items)">Real-World Evidence</a> <a href="https://blog.covance.com/tag/regulatory/" class="tag-cloud-link tag-link-324 tag-link-position-41" style="font-size: 17.210526315789pt;" aria-label="Regulatory (15 items)">Regulatory</a> <a href="https://blog.covance.com/tag/rheumatoid-arthritis/" class="tag-cloud-link tag-link-358 tag-link-position-42" style="font-size: 9.4736842105263pt;" aria-label="Rheumatoid Arthritis (5 items)">Rheumatoid Arthritis</a> <a href="https://blog.covance.com/tag/send/" class="tag-cloud-link tag-link-272 tag-link-position-43" style="font-size: 11.684210526316pt;" aria-label="send (7 items)">send</a> <a href="https://blog.covance.com/tag/vaccines/" class="tag-cloud-link tag-link-253 tag-link-position-44" style="font-size: 12.605263157895pt;" aria-label="vaccines (8 items)">vaccines</a> <a href="https://blog.covance.com/tag/xcellerate/" class="tag-cloud-link tag-link-8 tag-link-position-45" style="font-size: 16.289473684211pt;" aria-label="Xcellerate (13 items)">Xcellerate</a></div> </section></aside><!-- #secondary --> </div><!-- .row/not-found --> </div><!-- #content --> </div><!-- .container/.main-content --> <footer id="colophon" class="site-footer" itemscope itemtype="http://schema.org/WPFooter"> <div class="site-info"> <div class="container"> <span class="copyright">Copyright © 2020 Covance Inc. All rights reserved.</span> </div> </div> </footer><!-- #colophon --> <button aria-label="go to top" id="blossom-top"> <span><i class="fa fa-angle-up"></i>TOP</span> </button> </div><!-- #page --> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/all.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/v4-shims.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/sticky-kit.min.js?ver=1.1.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.min.js?ver=2.2.1'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.aria.min.js?ver=2.0.0'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/jquery.matchHeight.min.js?ver=0.7.2'></script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/wow.min.js?ver=1.1.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_data = {"lightbox":"","auto":"","loop":"","speed":"3000","animation":"fadeOut","child":"default","sticky":"","sticky_widget":"","header":"eight","url":"https:\/\/blog.covance.com\/wp-admin\/admin-ajax.php","rtl":""}; /* ]]> */ </script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/custom.min.js?ver=2.3.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_ajax = {"url":"https:\/\/blog.covance.com\/wp-admin\/admin-ajax.php","startPage":"1","maxPages":"30","nextLink":"https:\/\/blog.covance.com\/page\/2\/","autoLoad":"load_more","loadmore":"Load More Posts","loading":"Loading...","nomore":"No More Post","layouts":"two-col-right","plugin_url":"https:\/\/blog.covance.com\/wp-content\/plugins"}; /* ]]> */ </script> <script type='text/javascript' src='https://blog.covance.com/wp-content/themes/blossom-feminine-pro/js/ajax.min.js?ver=2.3.3'></script> <script type='text/javascript' src='https://blog.covance.com/wp-includes/js/wp-embed.min.js?ver=5.4'></script> <script type='text/javascript' src='https://stats.wp.com/e-202116.js' async='async' defer='defer'></script> <script type='text/javascript'> _stq = window._stq || []; _stq.push([ 'view', {v:'ext',j:'1:9.1',blog:'176650705',post:'0',tz:'-4',srv:'blog.covance.com'} ]); _stq.push([ 'clickTrackerInit', '176650705', '0' ]); </script> <script type="text/javascript"> if(typeof _satellite !== "undefined"){ _satellite.pageBottom(); } </script> </body> </html>